Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucose management practice project in cardiology outpatients
ChiCTR-ECS-11001793Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Dec 2011
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acarbose in carbohydrate malabsorption and type 2 diabetes mellitus (T2DM), sponsored by Chinese PLA General Hospital. Primary endpoints: Oral glucose tolerance test and Random blood glucose. Started Dec 2011; status: completed.
02
Drugs
acarbose
03
Conditions
carbohydrate malabsorptiontype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-ECS-11001793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ECS-11001793.